Our results suggest the antianhedonic effects of ketamine may reverse patterns of aberrant reward circuitry commonly seen in depression, by increasing NAc and subsequently decreasing Hb connectivity in both broadly distributed overlapping, as well as and distinct brain regions. This evidence concerns the gene GSTM1 and depressive disorder.